Methods for peptide therapeutics originated from the synthesis of insulin and adrenocorticotropic hormone (ACTH) for treating type I diabetes and endocrine disorders in human patients during the 1980s and 1990s [10]. The gene discussed is POMC; the disease is type 1 diabetes mellitus.